Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 24, 2023
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
Wed, August 23, 2023
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
Serge Belanger Reiterated (VRCA) at Strong Buy and Held Target at $10 on, Aug 23rd, 2023
Serge Belanger of Needham, Reiterated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $10 on, Aug 23rd, 2023.
Serge has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Serge's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Serge
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $12 on, Thursday, July 27th, 2023
- Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $14 on, Tuesday, July 25th, 2023
